Abstract: The present disclosure relates to pharmaceutical solutions of certain anti-N3pGlu Aß antibodies. Uses of such pharmaceutical solutions, including use in the treatment of Alzheimer's disease, are also disclosed.
| # | Name | Date |
|---|---|---|
| 1 | 202517008666-STATEMENT OF UNDERTAKING (FORM 3) [03-02-2025(online)].pdf | 2025-02-03 |
| 3 | 202517008666-Sequence Listing in PDF [03-02-2025(online)].pdf | 2025-02-03 |
| 4 | 202517008666-REQUEST FOR EXAMINATION (FORM-18) [03-02-2025(online)].pdf | 2025-02-03 |
| 5 | 202517008666-PROOF OF RIGHT [03-02-2025(online)].pdf | 2025-02-03 |
| 6 | 202517008666-POWER OF AUTHORITY [03-02-2025(online)].pdf | 2025-02-03 |
| 7 | 202517008666-FORM 18 [03-02-2025(online)].pdf | 2025-02-03 |
| 8 | 202517008666-FORM 1 [03-02-2025(online)].pdf | 2025-02-03 |
| 9 | 202517008666-DRAWINGS [03-02-2025(online)].pdf | 2025-02-03 |
| 10 | 202517008666-DECLARATION OF INVENTORSHIP (FORM 5) [03-02-2025(online)].pdf | 2025-02-03 |
| 11 | 202517008666-COMPLETE SPECIFICATION [03-02-2025(online)].pdf | 2025-02-03 |
| 12 | 202517008666-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [03-02-2025(online)].pdf | 2025-02-03 |
| 13 | 202517008666-FORM 3 [11-03-2025(online)].pdf | 2025-03-11 |
| 14 | 202517008666-RELEVANT DOCUMENTS [27-05-2025(online)].pdf | 2025-05-27 |
| 15 | 202517008666-MARKED COPIES OF AMENDEMENTS [27-05-2025(online)].pdf | 2025-05-27 |
| 16 | 202517008666-FORM 13 [27-05-2025(online)].pdf | 2025-05-27 |
| 17 | 202517008666-AMMENDED DOCUMENTS [27-05-2025(online)].pdf | 2025-05-27 |